Yayın:
Chlorine containing tetrahydropyrimidines: Synthesis, characterization, anticancer activity and mechanism of action

dc.contributor.authorMilovic, Emilija
dc.contributor.authorMatic, Ivana Z.
dc.contributor.authorPetrovic, Nina
dc.contributor.authorPasic, Ivana
dc.contributor.authorStanojkovic, Tatjana
dc.contributor.authorPetrovic, Milos R.
dc.contributor.authorBogdanovic, Goran A.
dc.contributor.authorArı, Ferda
dc.contributor.authorJankovic, Nenad
dc.contributor.buuauthorARI, FERDA
dc.contributor.departmentFen-Edebiyat Fakültesi
dc.contributor.departmentBiyoloji Bölümü
dc.contributor.orcid0000-0002-6729-7908
dc.contributor.researcheridAAG-7012-2021
dc.date.accessioned2025-02-10T08:03:24Z
dc.date.available2025-02-10T08:03:24Z
dc.date.issued2024-12-01
dc.description.abstractThe aim of the presented research was to explore anticancer potential of eleven newly synthesized tetrahydropyrimidine derivatives. The compounds were synthesized via Biginelli multicomponent one-pot reaction using different derivatives of vanillin, ethyl 4-chloroacetoacetate and (N-methyl)urea. The cytotoxic effects of the compounds were examined on three human malignant cell lines (HeLa, K562, and MCF7), and normal lung fibroblasts MRC-5. The mechanisms of anticancer activity were examined for two compounds 4a and 4b which showed the strongest and selective cytotoxicity against chronic myelogenous leukaemia K562 cells (IC50 = 1.76 +/- 0.09, and 1.66 +/- 0.05, respectively). The changes of matrix metalloproteinase 2 (MMP2), matrix metalloproteinase 9 (MMP9), and vascular endothelial growth factor A (VEGFA) were investigated in the K562 cell line, as well as oncomiRNA miR-10b, miR-23a described to have both features, depending on a specific type of malignancy, and miR-34a with mostly described as a tumour suppressor.
dc.description.sponsorshipMinistry of Science, Technological Development, and Innovations of the Republic of Serbia (NITRA)
dc.identifier.doi10.1016/j.bioorg.2024.107907
dc.identifier.issn0045-2068
dc.identifier.scopus2-s2.0-85207703386
dc.identifier.urihttps://doi.org/10.1016/j.bioorg.2024.107907
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0045206824008125
dc.identifier.urihttps://hdl.handle.net/11452/50233
dc.identifier.volume153
dc.identifier.wos001368352300001
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherAcademic Press Inc Elsevier Science
dc.relation.journalBioorganic Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.relation.tubitak451-03-66/2024-03/200378
dc.relation.tubitak451-03-66/2024-03/200043
dc.relation.tubitak123N941
dc.relation.tubitak0260206
dc.relation.tubitakCA21135
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectRapid colorimetric assay
dc.subjectMonastrol derivatives
dc.subjectMitotic kinesin
dc.subjectCell-lines
dc.subjectBiginelli
dc.subjectDihydropyrimidinones
dc.subjectGrowth
dc.subjectTetrahydropyrimidines
dc.subjectVanillin
dc.subjectK562
dc.subjectCytotoxicity
dc.subjectOncomirna
dc.subjectTumour suppressor
dc.subjectBiochemistry & molecular biology
dc.subjectChemistry
dc.titleChlorine containing tetrahydropyrimidines: Synthesis, characterization, anticancer activity and mechanism of action
dc.typeArticle
dspace.entity.typePublication
local.contributor.departmentFen-Edebiyat Fakültesi/Biyoloji Bölümü
local.indexed.atWOS
local.indexed.atScopus
relation.isAuthorOfPublication1dd517bb-3e11-411e-a8db-27d448dcd55e
relation.isAuthorOfPublication.latestForDiscovery1dd517bb-3e11-411e-a8db-27d448dcd55e

Dosyalar